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Paulinia cupana (guarana) is a Brazilian plant given great prestige in popular medicine, for example as being a potent stimulator of
brain functions. The authors assessed the effects of the long-term administration of guarana on the cognition of normal, elderly
volunteers. Forty-five volunteers were studied, with a random distribution in three experimental groups: placebo (n=15), caffeine
(n=15), and guarana (n=15), in a double-blind study.There were no significant cognitive alterations in these volunteers.
UNITERMS: Paulinia cupana (guarana). Cognition. Medicinal plants.
INTRODUCTION
The concept of adapti ve or resistant drugs has arisenin the past 20-30 years thanks to extensive researchdone by Soviet, Japanese and Korean scientists on
several plants, especially those from the Araliaceae family.
Although folkloric use of these plants has always
spurred curiosity, there have been, in general, few scientific
studies on these plants. In fact, it has been difficult to
observe any immediate effect of these plants in relation to
all the alleged therapeutic effects that have been reported
by popular medicine"' 12. It was only possible to verify
their typical effects and isolate their active ingredients2
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when investigations stopped searching for short-term
effects in normal animals, and demonstrated the plants'
protection against aggressive agents through long-term use.
Of ten adaptive plants studied in the former Soviet
Union, five have already been officially approved for
therapeutic use2: Panax ginseng, Aralia elata, Aralia
cordata, Acanthopanax senticocus (used for astronaut
preparation) and Oplopanax elatus.
In Brazil, our scientific community has devoted little
effort to investigating our vast flora for adaptive plants.
Therefore, it is not possible to find scientific studies
relevant to this matter. However, in Brazilian popular
medicine, several plants are used with the same purpose
as other folk medicine found in China and other countries.
Guarana (Paulinia cupana) and the Pfaffia paniculata are
good examples.
Guarana is attributed with powerful preventive and
curative actions (all without scientific proof) and, among
these, we can cite some of its indications: neuralgia,
migraine, arteriosclerosis, menstrual pain, weight loss,
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renal activation, bad digestion, heart and brain stimulation,
and othersl9•
Anthropologist A. HENMAN, in his 1986 study of
guarana 16,describes the use of this plant by the Satere-
Maue Indians who live in the Amazon, emphasizing its
use as a liquid preparation which is diluted and taken
several times during the day on a long-term basis. He also
reports that guarana has been used by these Indians for
centuries as a stimulant, headache medicine, and for relief
of cramps, etc.
In relation to its botanical classification, PIO
CORREA21 as well as HENMAN'6, describ~ guarana as
being from the Sapiendaceae family, with two subspecies:
Paulinia cupana var sorbilis and Paulinia cupana var
typica. Chemically guarana is characterized by its high-
grade caffeine, with a smaller quantity of theophylline and
theobomine. It is known that these substances do not have
pharmacological actions that can explain ill.l the therapeutic
effects popularly attributed to guarana. In fact, the central
stimulating effect of caffeine cannot explain the majority
of them3• On the other hand, a presence of a high
concentration of tannin in guarana has been described as
4-6 percent, according to HENMAN'6.
The following study considers the effect of the long-
term use of guarana on the cognition of normal, elderly
volunteers.
• At least a sixth grade education (to avoid bias in
cognitive assessment);
Free of medications;
No significant physical or mental disturbances.
The project was approved by the Ethics Committee
of the Federal University of Sao Paulo in Anima Nobili.
All volunteers signed a Term of Agreement to participate.
EXPERIMENTAL GROUPS
Three experimental groups were formed, each with
IS volunteers:
GROUP I-PLACEBO
GROUP II - CAFFEINE, in quantities equivalent to
doses of administered guarana. The purpose of this
group was to assess the different cognitive effects of
guarana and caffeine, if any.
GROUP III - GUARANA
The sample of guarana used was analyzed by
EMB RAPA (B razi Ii an Agropecu ari an Research
Company) and had the following components:
Moisture: 8.80%
Ash: 1.51%
Caffeine: 2.10%
Tannin: 16%
Evaluation instruments
*
The volunteers in each experimental group took two
capsules a day (one in the morning, one in the afternoon)
for 150 days of the study. Each capsule contained 500 mg
of powdered guarana; the capsules of caffeine contained
12.5 mg. The placebo was brown sugar (500 mg/capsule).
The doses of I gram of guarana per day was decided
upon after studying the recommendations of laboratories
that sold the product, and a previous study done by this
department13•
All capsules were identical since this was a double-
blind study, and volunteers were
randomly divided into one of the
three experimental groups.
Placebo
*
Placebo
*
Basic Guarana Intermediate Guarana Final
Assessment Caffeine Assessment Caffeine Assessment
PATIENTS AND METHODS
Forty-five volunteers fit the following selection
criteria:
Over 60 years-old (several studies have demonstrated
that, after the age of 50-55, a decline in cognitive
functions begins, which does not mean any
pathologic manifestation6. 15;
(no treatment) (3 months of treatment)
[
• Clinical evaluation
• Laboratory
* • Psychological tests
• Sleep scale
• Anxiety inventory
Figure 1 - The study procedure.
(5 months of treatment)
1. Cognitive evaluation
The Mini-Mental Statel() was
used as screening for dementia with
a cut-off score of 23 points. Among
neuropsychological assays, we used
Digital Span24 to assess immediate
memory; Free Recall for recent
"'*" . %t:«W.
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memory'; Digital Symbol to evaluate psychomotor activity
and concentration8. 14; Cancellation tests to verify vigilance
and attention7; and, finally, the Mosaic test for visual and
spacial organization '8.
The Raven - Progressive Matrices (Advanced Scale)
was used. It is indicated to assess general abilities, having
shown sensitivity to detect reasoning and visual perception
damages.
2. Sleep assessment scale
To verify possible drug interferences in sleep during
treatment4•
3. Anxiety assessment scale
We used the State-Trait Anxiety Inventory22.
Experimental Procedure
widower; 25 volunteers had finished high school, 15 had
finished primary school and 5 had graduated from
university.
Table 1
Immediate (Digit Span) and recent (Free Recall)
memory assessment of the 45 volunteers in the
three phases of the study
(results are average score and standard deviation)
Cognitive Phases of treatment
tests Groups Initial Interm. Final
Placebo 11.4:t2 12.1:t1 12.1:t2
Digit Span Caffeine 11.4:t2 12.5:t2 12.6:t2
Guarana 10.3:t2 11.8:t1 11.7:t1
Maximum score: 18
Table I shows the results of two cognitive tests used
for memory assessment. There were no significant
differences.
Table 2
Assessment of Psychomotor Performance (Digit
Symbol), Attention (Cancellation Test) and Visual
Spacial Organization (Mosaic)
(results are average score and standard deviation)
Maximum score: 27
Cognitive Phases of treatment
tests Groups Initial Interm. Final
Placebo 34.6:t7 36.6:t8 40.8:t8*
Digit Symbol Caffeine 31.7:t11 37.5:t10 39.0:t12*
Guarana 35.8:t11 40.0:t12 42.6:t12*
Maximum score: 67
Maximum score: 112
Each volunteer was submitted to a clinical evaluation
(physical and laboratory exams) followed by the Mini-
Mental State exam and neuropsychological tests to
determine the basal cognitive state. We also applied the
Sleep Scale and the Anxiety Inventory.
The selected volunteers initiated the intake of one of
the three substances with initial clinical follow-up every
week, and then every month (to receive more capsules,
thus providing not only the necessary clinical care, but
also assuring us that the substances were being used
regularly). In the third and fifth month after beginning
treatment, the complete evaluation of the basis phase was
again repeated (Fig.1).
STATISTICAL ANALYSIS
Data was analysed using non-parametria tests. For
the analysis of dependent samples, we used the Friedman
test and, for independent samples, we used the Kruskal
Wallis test. The significance level was 5 percent.
The study was developed at the Center of Clinical
Research of the Department of Psychobiology at the
Federal University of Sao Paulo from January to September
1992.
Placebo
Free Recall Caffeine
Guarana
Placebo
Cancellation Caffeine
Guarana
14.6:t4
14.4:t3
13.7:t2
40.9:t10
40.2:t7
42.0:t6
13.9:t4
14.4:t2
12.8:t3
40.6:t7
42.7:t6
44.3:t6
14.5:t3
14.4:t3
13.4:t4
42.9:t7
42.9:t7
44.2:t7
RESULTS
Mosaic
Placebo
Caffeine
Guarana
32.2:t11
23.8:t12
35.9:t9
34.9:t10
30.0:t13
41.0:t9
37.2:t9
30.3:t15
42.4:t7*
These are the following social and demographic
characteristics of the 45 subjects: mean age was 6560.76;
20 were male (44 percent); 39 married, 5 bachelors, and 1
Maximum score: 50
* p<0.05 in relation to initial assessment (Friedman test
for dependent samples)
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DISCUSSION
Scores
which was not confirmed by the tests; he was under
caffeine. Nobody reported a rise in libido or improved
sexual performance (through spontaneous or stimulated
questionnaires).
Laboratory exams remained stable throughout the
study and during extended control for two months
afterwards.
It is important to emphasize the great interest and
work demonstrated by all volunteers, not only in helping
.with the study, but in also in maintaning the hope offinding
a solution for the memory loss that had brought them to
our hospital. The withdrawal of two volunteers (one due
to insomnia and another due to tachycardia) was a decision
made more by the researcher than by the patient.
score: 12
Maximum
Placebo 38.8::t9 37.0::t8
Caffeine 37.6::t8 36.0::t7
Guarana 38.3::t8 40.2::t5
Placebo 6.1::t2 6.8::t2
Caffeine 5.2::t2 6.1::t3
Guarana 5.7::t1 6.6::t1
Table 3
Anxiety level state trait measured by anxiety inventory and
reasoning assessment (Raven) of the 45 volunteers
(results are average score and standard deviation)
Raven
Assessment Phases of treatment
Groups Initial Interm. Final
Placebo 39.4::t9 38.4::t8 36.3::t8
State Caffeine 35.8::t10 33.8::t13 31.5::t9
Guarana 33.0::t6 32.8::t4 32.8:t5
Table 2 shows that the volunteers presented an
improvement in the Digit Symbol test when the final and
initial assessment were compared, although there were no
differences between the three groups (Placebo, Caffeine
and Guarana). In the results of the Mosaic test, the guarana
group showed significant improvement, but it is important
to note that the initial results of this group were already
higher in comparison to the other two groups, although
not significantly.
Finally, Table 3 shows data in relation to the
volunteers' levels of anxiety measured by the Anxiety
Inventory and the detection of affected reasoni ng
(Progressive Matrices - Raven). There were no significant
alterations.
One patient, under placebo, complained of persistent
insomnia during the first week of the experiment, with no
improvement after administration of only 1 capsule/day.
She only recovered her sleep after interruption of the
treatment. There were no other qualitative or quantitative
alterations in volunteers' sleep.
Four participants complained of "burning in the
stomach"; three were taking guarana and one was taking
caffeine. This was improved by decreasing the doses to
500mg/day and the intake of capsules only after meals.
One volunteer who was taking guarana had to interrupt
treatment due to tachycardia that was clinically confirmed.
Some curious facts were reported by the volunteers.
One woman said that the treatment was "rejuvenating"
and "bringing back her joy for life"; she was under placebo.
Another said repeatedly that his memory had improved,
Trait
Results show that guarana, in the studied doses, did
not cause enough alterations to characterize any detectable
clinical manifestation. Only in the Mosaic test was there a
statistical improvement (Guarana Group); however, only
one result is not relevant for our study. It is obvious that
the statistical difference found in the Digit Symbol test
was due to learning, since it was found in all the studied
groups. In general, these results are similar to those found
in another study on the immediate effects of guarana 13.
It would seem who the prestige of guarana comes
only from its popularity, at least in the studied
aspects. Certainly many of the reported effects
come from the fact that caffeine is a stimulant
and from the "placebo" effect, therefore
turning guarana into a tonic beverage.
However, it is not totally free from side
effects, since four volunteers showed some
discomfort, with one not completing the study
<30 due to tachycardia, which confirms several
reports of people who are sensitive to guarana
31-40
medium-low and present tachycardia (GALDUROZ &
41-50 CARLINI, data not published).
At the beginning of this study, we hadmedium-high~~~~~~~~~~~~~~~~~~~~~~~~~~- in mind that the great quantity oftannins~ in
>50 guarana (our sample had 16 percent) could
high anxiety perhaps act as a "captor" of free-radicals and,
therefore, justify some of the effects that are
reported by the population. However, one
cannot totally disregard that this plant has an
adaptive action, since -it has already been
observed, during in vitro lipid peroxidation,
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that guarana acts as an antioxidant (MATTEI R, et aL,
data not published).
There are several studies that try to study substances
or plants which improve cognition either in normal people
or in the mentally ills. 17.20 and, unfortunately, guarana has
not shown any success.
However, two issues can be brought up to explain
these failures: treatment time with guarana was insufficient,
although studies on cognition enhancement drugs state that
a drug is not efficient when it shows no results after 5 to 6
months of administration23• On the other hand, another
argument in favor of guarana is that the neuropsychological
tests employed were not sensitive enough to detect the
expected alterations.
In any case, we do know that this 'is the first scientific
study regarding chronic administration of guarana in
human beings.
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RESUMO
A Paulfnia cupana (0 guarana) e uma planta da flora brasileira que goza de grande prestigio na medicina popular, entre eles
de ser potente estimulante das funyoes cerebrais. Os autores avaliaram os efeitos da administrayao cronica da guarana sobre
a cogniyao de voluntarios idosos normais. Foram estudados 45 voluntarios, sendo distribufdos aleatoriamente para um dos
tres grupos experimentais: Placebo (n=15), Cafefna (n=15) e Guarana (n=15), em estado duplo-cego. Nao obteve-se nenhuma
mudanya significativa na cogniyao desses voluntarios. I
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